Literature DB >> 9683661

The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex.

J Glienke1, Y Sobanov, C Brostjan, C Steffens, C Nguyen, H Lehrach, E Hofer, F Francis.   

Abstract

Interactions of natural killer cell receptors with their cognate ligands play a major role in regulating NK cell function. The NKG2 gene family encodes several highly similar proteins, which are known to form heterodimers with the CD94 receptor. These dimers play a role in the inhibition as well as the activation of NK cells. We have analyzed the gene structures of the NKG2C, D, E, and F genes, and determined their genomic organization. Restriction mapping and sequencing revealed the four genes to be closely linked to one another, and of the same transcriptional orientation. An exon duplication within the NKG2C and E genes was identified, although the duplicated version of this exon has not yet been found in mRNA sequences. The NKG2C, E, and F genes, despite being highly similar, are variable at their 3' ends. We show that NKG2C consists of six exons, whereas NKG2E has seven, and the splice acceptor site for the seventh exon occurs in an Alu repeat. NKG2F consists of only four exons and part of exon IV is in some cases spliced to the 5' end of the NKG2D transcript. NKG2D has only a low similarity to the other NKG2 genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683661     DOI: 10.1007/s002510050420

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  27 in total

Review 1.  The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.

Authors:  Francisco Borrego; Madhan Masilamani; Alina I Marusina; Xiaobin Tang; John E Coligan
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  NKG2D Receptor and Its Ligands in Host Defense.

Authors:  Lewis L Lanier
Journal:  Cancer Immunol Res       Date:  2015-06       Impact factor: 11.151

3.  DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells.

Authors:  Alba Fernández-Sánchez; Aroa Baragaño Raneros; Reyes Carvajal Palao; Ana B Sanz; Alberto Ortiz; Francisco Ortega; Beatriz Suárez-Álvarez; Carlos López-Larrea
Journal:  Epigenetics       Date:  2012-12-12       Impact factor: 4.528

4.  Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer.

Authors:  Hiroaki Saito; Tomohiro Osaki; Masahide Ikeguchi
Journal:  Gastric Cancer       Date:  2011-05-31       Impact factor: 7.370

5.  Variable NKG2 expression in the peripheral blood lymphocytes of rhesus monkeys.

Authors:  M L Labonte; N L Letvin
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

Review 6.  The role of CD94/NKG2 in innate and adaptive immunity.

Authors:  Anasuya Gunturi; Rance E Berg; James Forman
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

7.  A truncated human NKG2D splice isoform negatively regulates NKG2D-mediated function.

Authors:  Cynthia L Baldwin; Taku Kambayashi; Mobin A Karimi; Oscar Aguilar; Baixiang Zou; Michael H Bachmann; James R Carlyle
Journal:  J Immunol       Date:  2014-08-04       Impact factor: 5.422

8.  Variation in the ligand binding domains of the CD94/NKG2 family of receptors in the squirrel monkey.

Authors:  Michelle L LaBonte; Joanne Russo; Stephanie Freitas; Dawn Keighley
Journal:  Immunogenetics       Date:  2007-09-25       Impact factor: 2.846

Review 9.  Biology and clinical impact of human natural killer cells.

Authors:  Sherif S Farag; Jeffrey B VanDeusen; Todd A Fehniger; Michael A Caligiuri
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

10.  Transcriptional Analysis of the Guinea Pig Mucosal Immune Response to Intravaginal Infection with Herpes Simplex Virus Type 2.

Authors:  Ronald L Veselenak; Gregg N Milligan; Aaron L Miller; Richard B Pyles; Nigel Bourne
Journal:  Virology       Date:  2018-03-28       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.